Specific glucocorticosteroid compound having...

Details Specific glucocorticosteroid compound having... Specific glucocorticosteroid compound having...

2007-11-06

2007-11-06

Badio, Barbara P. (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S180000, C552S610000

Reexamination Certificate

active

10564299

ABSTRACT:
A compound of formula (I):or a physiologically acceptable solvate thereof.

REFERENCES:
patent: 3856828 (1974-12-01), Phillipps et al.
patent: 5552438 (1996-09-01), Christensen, IV
patent: 6172054 (2001-01-01), Clark
patent: 6245804 (2001-06-01), Lehmann et al.
patent: 6395738 (2002-05-01), Ohshima et al.
patent: 6897224 (2005-05-01), Jaroch et al.
patent: 1384372 (1975-02-01), None
patent: 1514476 (1978-06-01), None
patent: 2079755 (1982-01-01), None
patent: 2137206 (1984-10-01), None
patent: WO 89/03390 (1989-04-01), None
patent: WO 93/13055 (1993-07-01), None
patent: WO 95/34534 (1995-12-01), None
patent: WO 97/41867 (1997-11-01), None
patent: WO 98/30537 (1998-07-01), None
patent: WO 98/54159 (1998-12-01), None
patent: WO 99/16766 (1999-04-01), None
patent: WO 99/32127 (1999-07-01), None
patent: WO 99/47505 (1999-09-01), None
patent: WO 99/62875 (1999-12-01), None
patent: WO 00/66590 (2000-11-01), None
patent: WO 01/04118 (2001-01-01), None
patent: WO 01/10143 (2001-02-01), None
patent: WO 01/16128 (2001-03-01), None
patent: WO 01/42193 (2001-06-01), None
patent: WO 02/00679 (2002-01-01), None
patent: WO 02/02565 (2002-01-01), None
patent: WO 02/26722 (2002-04-01), None
patent: WO 02/40030 (2002-05-01), None
patent: WO 02/50021 (2002-06-01), None
patent: WO 02/066422 (2002-08-01), None
patent: WO 02/070490 (2002-09-01), None
patent: WO 02/076933 (2002-10-01), None
patent: WO 03/008277 (2003-01-01), None
patent: WO 03/024439 (2003-03-01), None
patent: WO 03/042160 (2003-05-01), None
patent: WO 03/059899 (2003-07-01), None
patent: WO 03/061651 (2003-07-01), None
patent: WO 03/072539 (2003-09-01), None
patent: WO 03/082280 (2003-10-01), None
patent: WO 03/082787 (2003-10-01), None
patent: WO 03/082827 (2003-10-01), None
patent: WO 03/086294 (2003-10-01), None
patent: WO 03/101932 (2003-12-01), None
patent: WO 03/104195 (2003-12-01), None
patent: WO 2004/005229 (2004-01-01), None
patent: WO 2004/009016 (2004-01-01), None
patent: WO 2004/009017 (2004-01-01), None
patent: WO 2004/016578 (2004-02-01), None
patent: WO 2004/018429 (2004-03-01), None
patent: WO 2004/022547 (2004-03-01), None
patent: WO 2004/024728 (2004-03-01), None
patent: WO 2004/026248 (2004-04-01), None
patent: WO 2004/037768 (2004-05-01), None
patent: WO 2004/037773 (2004-05-01), None
patent: WO 2004/037807 (2004-05-01), None
patent: WO 2004/039762 (2004-05-01), None
patent: WO 2004/039766 (2004-05-01), None
patent: WO 2004/056823 (2004-07-01), None
patent: WO 2004/103998 (2004-12-01), None
patent: WO 03/091204 (2006-11-01), None
Austin et al., “Mometasone furoateis a less specific glucocorticoid than fluticasone propionate,”Eur Resp J. 20(6):1386-1392 (Dec. 2002).
Fuji et al., “Novel phosphodiesterase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen,”J Pharmacol Exp Ther284(1):162 (1998).
Landells et al., “Oral administration of the phosphodiesterase (PDE)4 inhibitor, V11294A inhibits ex-vivo agonis-induced-cell activation,”Eur Resp J(/annu Cong Eur Resp Soc. Geneva) 12(Suppl. 28) Abst P2393 (Sep. 1998).
Rachwal et al., “Chemistry of loteprednol crabonate and related steriods. II. Reactions at ring C and NMR structural studies of the resulting compounds,”Steroids63 (4):193-201 (1998).
Ray et al., “Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor χ, and inhibition by glucocorticoids,”Biochem J. 328:707-715 (Dec. 1997).
Phillips, GH et al., “Synthesis and structure activity Relationships in a series of Anti-inflammatory Corticosteroid Analogues, Halomethyl Androstane—17B-carbothioates and -17B-carboselenoates,” Journal of Medicinal Chemistry 1994, 37, 3717-3729.
Ueno et al., “Synthesis and evaluation of anti-inflammatory activities of a series of corticosteroid 17.alpha.-esters containing a functional group,”Journal of Medicinal Chemistry34(8):2468-2471 (Aug. 1991).

Affiliated with

Also associated with

Rating

Specific glucocorticosteroid compound having... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Specific glucocorticosteroid compound having..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific glucocorticosteroid compound having... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3854745